The agency is considering whether compounding pharmacies should be allowed to produce BPC-157, TB-500 and other previously banned peptides.

The Agency for Healthcare Research and Quality slowed the awarding of new grants last year. Now it is stopping existing ones.

Senator Bill Cassidy, who is believed to hold the deciding vote in the Senate health committee for Dr. Erica Schwartz’s confirmation, had declined for days to say whether he would back her.

Agency scientists are advising against allowing widespread use of several peptide injections. Robert F. Kennedy Jr., the health secretary, has said people should be free to experiment.

For the first time, officials have acknowledged problems with the No Surprises Act, which has led to huge payments.

The administration canceled federal grants to organizations across the country, accusing them of encouraging premarital sex. New criteria say programs should stress abstinence.

New research also shows that children and high-risk adult populations have been particularly affected.

Retirement communities already grappling with labor shortages are being forced to terminate caregivers at a time when more Americans are living longer.

A new nonprofit wants to streamline gene therapy for diseases often avoided by pharmaceutical companies — making treatment more like a routine procedure than a bespoke drug.

Eighteen Americans were isolated for weeks in a Nebraska quarantine facility after being exposed to the deadly virus on a cruise ship. Many found the experience traumatic.

During the Covid-19 pandemic, wastewater testing became a virus warning system. Now, scientists are using the approach to understand how communities eat.